Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.

Erkan Özcan, N Işıl Saygun, Rahşan Ilıkçı, Yıldırım Karslıoğlu, Uğur Muşabak, Sait Yeşillik
Author Information
  1. Erkan Özcan: Department of Periodontology, Gülhane Military Medicine Academy, Dental Sciences Center, Ankara, Turkey. drdterkan@mynet.com.
  2. N Işıl Saygun: Department of Periodontology, Gülhane Military Medicine Academy, Dental Sciences Center, Ankara, Turkey.
  3. Rahşan Ilıkçı: Department of Immunology, Gülhane Military Medicine Academy, Ankara, Turkey.
  4. Yıldırım Karslıoğlu: Department of Pathology, Gülhane Military Medicine Academy, Ankara, Turkey.
  5. Uğur Muşabak: Department of Immunology, Gülhane Military Medicine Academy, Ankara, Turkey.
  6. Sait Yeşillik: Department of Immunology, Gülhane Military Medicine Academy, Ankara, Turkey.

Abstract

OBJECTIVE: Visfatin is an adipocytokine that plays a role in regulating periodontal inflammation by as yet identified mechanisms. It has been suggested that visfatin mediates inflammation via activation of the nuclear factor-kappa B (NF-κB) and phosphatidylinositol 3-kinase (PI3k) signaling pathways which play a role in the inhibition of neutrophil apoptosis. The aim of this study was to investigate the expression of visfatin, NF-κB (NF-κB and NF-κB), PI3k, tumor necrosis factor alpha (TNF-α), and interleukin-1 beta (IL-1β) in the tissue of healthy individuals and patients with periodontitis.
MATERIALS AND METHODS: Tissue biopsy samples were obtained from 21 patients with chronic periodontitis and from the gingiva of 19 healthy individuals undergoing crown lengthening. The mRNA expression levels of visfatin, NF-κB, PI3k, TNF-α, and IL-1β were evaluated by quantitative real-time PCR (qPCR). Also, visfatin protein expression was measured by immunohistochemistry.
RESULTS: Both qPCR and immunohistochemistry results revealed that the visfatin expression was higher in the tissues with periodontitis than in healthy tissues (P < 0.01). Similarly, the mRNA expression levels of NF-κB, PI3k, and IL-1β were higher in tissues with periodontitis than in healthy gingival tissues (P < 0.01). Visfatin was positively correlated with the levels of NF-κB (r = 0.549, P < 0.05), NF-κB (r = 0.636, P < 0.05), PI3k (r = 0.682, P < 0.01), TNF-α (r = 0.558, P < 0.05), and IL-1β (r = 0.686, P < 0.01) in the tissues with periodontitis.
CONCLUSIONS: Our results demonstrated that increased visfatin was associated with the expression of NF-κB and PI3k which may play a role in the pathogenesis of periodontitis. We suggest that increased visfatin may contribute to the inhibition of neutrophil apoptosis via the NF-κB and PI3k signaling pathways.
CLINICAL RELEVANCE: Understanding the role of visfatin in periodontitis will enable the development of new treatment methods for inflammation.

Keywords

References

  1. J Periodontol. 2015 Jul;86(7):882-9 [PMID: 25811944]
  2. Ann Surg. 2014 May;259(5):1007-17 [PMID: 24169192]
  3. J Periodontol. 2005 Jul;76(7):1148-53 [PMID: 16018758]
  4. Clin Oral Investig. 2015 May;19(4):921-8 [PMID: 25164155]
  5. Eur J Med Res. 2013 May 01;18:12 [PMID: 23634778]
  6. J Periodontol. 2016 Apr;87(4):443-51 [PMID: 26561994]
  7. Int J Mol Med. 2011 Apr;27(4):607-15 [PMID: 21327328]
  8. Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S64-71 [PMID: 19026118]
  9. Biol Pharm Bull. 2015;38(7):961-5 [PMID: 26133703]
  10. Clin Oral Investig. 2014 Jan;18(1):171-8 [PMID: 23404558]
  11. Cardiovasc Res. 2008 May 1;78(2):356-65 [PMID: 18093986]
  12. Mediators Inflamm. 2014;2014:912821 [PMID: 24707118]
  13. Eur J Dent. 2010 Oct;4(4):454-61 [PMID: 20922166]
  14. Int J Dev Biol. 2012;56(10-12):959-67 [PMID: 23417417]
  15. Biochim Biophys Acta. 2008 May;1783(5):886-95 [PMID: 18241674]
  16. Dis Markers. 2012;32(6):383-8 [PMID: 22684235]
  17. Acta Odontol Scand. 1964 Feb;22:121-35 [PMID: 14158464]
  18. J Pharmacol Exp Ther. 2007 Jan;320(1):56-63 [PMID: 17041006]
  19. J Periodontol. 2012 May;83(5):629-34 [PMID: 21966944]
  20. Apoptosis. 2013 Dec;18(12):1469-80 [PMID: 23982477]
  21. Mediators Inflamm. 2013;2013:437123 [PMID: 24058270]
  22. J Immunol. 2011 Jun 1;186(11):6474-84 [PMID: 21518975]
  23. Indian J Dent Res. 2013 Jan-Feb;24(1):147 [PMID: 23852253]
  24. Diabetes Care. 2008 Apr;31(4):758-60 [PMID: 18184904]
  25. Front Biosci (Landmark Ed). 2009 Jan 01;14:2372-85 [PMID: 19273206]
  26. J Periodontol. 2011 Sep;82(9):1314-9 [PMID: 21309715]
  27. Front Oral Biol. 2012;15:56-83 [PMID: 22142957]
  28. Infect Immun. 2010 Oct;78(10):4151-6 [PMID: 20679442]
  29. Immunol Lett. 2011 Sep 30;139(1-2):93-101 [PMID: 21645546]
  30. Lancet. 2004 Jan 10;363(9403):157-63 [PMID: 14726171]
  31. J Clin Periodontol. 2003 Jul;30(7):616-23 [PMID: 12834499]
  32. J Mol Endocrinol. 2011 Jul 04;47(1):13-21 [PMID: 21471274]
  33. Int J Med Microbiol. 2015 Sep;305(6):493-500 [PMID: 26005182]
  34. PLoS One. 2013;8(1):e55249 [PMID: 23383125]
  35. Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9 [PMID: 19351806]
  36. J Clin Periodontol. 2013 Aug;40(8):757-64 [PMID: 23742695]
  37. Pflugers Arch. 2010 Mar;459(4):619-30 [PMID: 19898975]
  38. J Biol Rhythms. 2001 Oct;16(5):444-56 [PMID: 11669418]
  39. Mol Oral Microbiol. 2014 Dec;29(6):258-69 [PMID: 25052571]
  40. Infect Immun. 2012 Apr;80(4):1615-23 [PMID: 22252875]
  41. J Periodontol. 2015 Jun;86(6):795-800 [PMID: 25786566]
  42. J Leukoc Biol. 2013 Sep;94(3):481-92 [PMID: 23804809]
  43. J Clin Invest. 2004 May;113(9):1318-27 [PMID: 15124023]
  44. Acta Odontol Scand. 1963 Dec;21:533-51 [PMID: 14121956]
  45. J Physiol Pharmacol. 2013 Jun;64(3):377-85 [PMID: 23959735]
  46. Cell Tissue Res. 2015 Feb;359(2):605-18 [PMID: 25358398]
  47. Eur J Pharmacol. 2013 Aug 15;714(1-3):7-14 [PMID: 23764465]

MeSH Term

Adult
Chronic Periodontitis
Cytokines
Female
Humans
Immunohistochemistry
Interleukin-1beta
Male
NF-kappa B
Nicotinamide Phosphoribosyltransferase
Phosphatidylinositol 3-Kinase
RNA, Messenger
Real-Time Polymerase Chain Reaction
Tumor Necrosis Factor-alpha

Chemicals

Cytokines
Interleukin-1beta
NF-kappa B
RNA, Messenger
Tumor Necrosis Factor-alpha
Nicotinamide Phosphoribosyltransferase
nicotinamide phosphoribosyltransferase, human
Phosphatidylinositol 3-Kinase

Word Cloud

Created with Highcharts 10.0.0NF-κBvisfatinPI3kexpressionperiodontitisP < 0tissuesr = 0roleinflammationIL-1βhealthy01factor-kappaB3-kinaseTNF-αlevels05VisfatinperiodontalvianuclearphosphatidylinositolsignalingpathwaysplayinhibitionneutrophilapoptosisindividualspatientsmRNAqPCRimmunohistochemistryresultshigherincreasedassociatedmayOBJECTIVE:adipocytokineplaysregulatingyetidentifiedmechanismssuggestedmediatesactivationaimstudyinvestigatetumornecrosisfactoralphainterleukin-1betatissueMATERIALSANDMETHODS:Tissuebiopsysamplesobtained21chronicgingiva19undergoingcrownlengtheningevaluatedquantitativereal-timePCRAlsoproteinmeasuredRESULTS:revealedSimilarlygingivalpositivelycorrelated549636682558686CONCLUSIONS:demonstratedpathogenesissuggestcontributeCLINICALRELEVANCE:UnderstandingwillenabledevelopmentnewtreatmentmethodsIncreasedApoptosisNicotinamidephosphoribosyltransferaseNuclearPeriodontitisPhosphatidylinositol

Similar Articles

Cited By